Journal of Endocrinological Investigation

, Volume 18, Issue 2, pp 147–149 | Cite as

Cancer in iodine-131 exposed patients

  • P. Hall
  • L. -E. Holm


Thyroid cancer radiation 131I treatment 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Conard R.A. Late radiation effects in Marshall Islanders exposed to fallout 28 years ago. In: Boice J.D. Jr., Fraumeni J.F. Jr. (Eds.), Radiation carcinogenesis: epidemiology and biological significance. Raven Press, New York, 1984, p. 57.Google Scholar
  2. 2.
    Hamilton T.E., van Belle G., LoGerfo J.P. Thyroid neoplasia in Marshall Islanders exposed to nuclear fallout. JAMA 258: 629, 1987.PubMedCrossRefGoogle Scholar
  3. 3.
    Holm L.-E., Wiklund K.E., Lundell G.E. Cancer risk in population examined with diagnostic doses of 131|. J. Natl. Cancer. Inst. 81: 302, 1989.PubMedCrossRefGoogle Scholar
  4. 4.
    Holm L.-E., Wiklund K.E., Lundel G.E. Thyroid cancer after diagnostic doses of iodine-131: a retrospective cohort study. J. Natl. Cancer. Inst. 80: 1132, 1988.PubMedCrossRefGoogle Scholar
  5. 5.
    Saenger E.L., Thoma G.E., Tompkins E.A. Incidence of leukemia following treatment of hyperthyroidism. Preliminary report of the Cooperative Thyrotoxicosis Therapy Follow-up Study. JAMA. 205: 855, 1968.Google Scholar
  6. 6.
    Pochin E.E. Long term hazards of radioiodine treatment of thyroid carcinoma. In: Hedinger C.E. (Eds.), Thyroid cancer. UICC Monograph Series, vol. 12. Springer-Verlag, Berlin, 1969, 293.Google Scholar
  7. 7.
    Bricker H., Hansen H.S., Andersen A.P. Induction of leukaemia by 131| treatment of thyroid carcinoma. Br J Cancer. 28: 232, 1973.CrossRefGoogle Scholar
  8. 8.
    Hoffman D.A. Late effects of I-131 therapy in the United States. In Boice J.D. Jr, Fraumeni J.F. Jr (Eds.), Radiation carcinogenesis: epidemiology and biological significance. Raven Press, New York, 1984, p. 273.Google Scholar
  9. 9.
    Edmond C.J., Smith T. The long-term hazards of the treatment of thyroid cancer with radioiodine. Br. J. Radiol. 59: 45, 1986.CrossRefGoogle Scholar
  10. 10.
    Goldman M.B., Maloof F., Monson R.R., Aschengrau A., Cooper D.S., Ridgway E.C. Radioactive iodine therapy and breast cancer. A follow-up study of hyperthyroid women. Am. J. Epidemiol. 127: 969, 1988.Google Scholar
  11. 11.
    Goldman M.B., Monson R.R., Mallof F. Cancer mortality in women with thyroid disease. Cancer Res. 50: 2283, 1990.PubMedGoogle Scholar
  12. 12.
    Hoffman D.A., McConahey W.M., Diamond E.L., Kurland L.T. Mortality in women treated for hyperthyroidism. Am. J. Epidemiol. 115: 243, 1982.PubMedGoogle Scholar
  13. 13.
    International Commission on Radiological Protection, radiation dose to patients from radiopharmaceuticals. ICPR Publication 53. Pergamon Press, Oxford, 1988.Google Scholar
  14. 14.
    Holm L.-E., Hall P., Wiklund K. Cancer risk after iodine-131 therapy for hyperthyroidism. J. Natl. Cancer. Inst. 83: 1072, 1991.PubMedCrossRefGoogle Scholar
  15. 15.
    Hall P., Holm L.-E., Lundell G. Cancer risks in thyroid cancer patients. Br. J. Cancer. 64: 159, 1991.PubMedCentralPubMedCrossRefGoogle Scholar
  16. 16.
    Hall P., Boice JD., Berg G. Leukemia incidence after iodine-131 exposure. Lancet 340: 1, 1992.PubMedGoogle Scholar

Copyright information

© Italian Society of Endocrinology (SIE) 1995

Authors and Affiliations

  • P. Hall
    • 1
  • L. -E. Holm
    • 1
  1. 1.Department of General Oncology, RadiumhemmetKarolinska HospitalStockholmSweden

Personalised recommendations